Breast Cancer: Risk Assessment, Screening, and Primary Prevention
- PMID: 36759097
- DOI: 10.1016/j.mcna.2022.10.007
Breast Cancer: Risk Assessment, Screening, and Primary Prevention
Abstract
This review provides an outline of a risk-based approach to breast cancer screening and prevention. All women should be assessed for breast cancer risk starting at age 18 with identification of modifiable and non-modifiable risk factors. Patients can then be stratified into average, moderate, and high-risk groups with personalized screening and prevention plans. Counseling on breast awareness and lifestyle changes is recommended for all women, regardless of risk category. High-risk individuals may benefit from additional screening modalities such as MRI and chemoprevention and should be managed closely by a multidisciplinary team.
Keywords: Aromatase inhibitors; Breast MRI; Breast cancer; Breast cancer risk; Chemoprophylaxis; Mammogram; Prophylactic surgery; SERM.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Breast cancer prevention.Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20. Breast J. 2015. PMID: 25413630
-
A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.Contemp Clin Trials. 2017 May;56:25-33. doi: 10.1016/j.cct.2017.02.009. Epub 2017 Feb 28. Contemp Clin Trials. 2017. PMID: 28257920 Free PMC article. Clinical Trial.
-
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.Ann Ital Chir. 2019;90:1-2. Ann Ital Chir. 2019. PMID: 30872561
-
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.Acta Oncol. 2018 Oct;57(10):1275-1283. doi: 10.1080/0284186X.2018.1481291. Epub 2018 Jun 8. Acta Oncol. 2018. PMID: 29882455
-
Breast cancer genetics and risk assessment: an overview for the clinician.Climacteric. 2023 Jun;26(3):229-234. doi: 10.1080/13697137.2023.2184254. Epub 2023 Apr 3. Climacteric. 2023. PMID: 37011658 Review.
Cited by
-
Intelligent scoring system based on dynamic optical breast imaging for early detection of breast cancer.Biomed Opt Express. 2024 Feb 9;15(3):1515-1527. doi: 10.1364/BOE.515135. eCollection 2024 Mar 1. Biomed Opt Express. 2024. PMID: 38495695 Free PMC article.
-
Unlocking the complete blood count as a risk stratification tool for breast cancer using machine learning: a large scale retrospective study.Sci Rep. 2024 May 12;14(1):10841. doi: 10.1038/s41598-024-61215-y. Sci Rep. 2024. PMID: 38736010 Free PMC article.
-
Contrast Enhancement in Breast Cancer: Magnetic Resonance vs. Mammography: A 10-Year Systematic Review.Diagnostics (Basel). 2024 Oct 28;14(21):2400. doi: 10.3390/diagnostics14212400. Diagnostics (Basel). 2024. PMID: 39518367 Free PMC article. Review.
-
Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review.Nutrients. 2023 Dec 19;16(1):2. doi: 10.3390/nu16010002. Nutrients. 2023. PMID: 38201832 Free PMC article. Review.
-
Molecular Pathways of Genistein Activity in Breast Cancer Cells.Int J Mol Sci. 2024 May 20;25(10):5556. doi: 10.3390/ijms25105556. Int J Mol Sci. 2024. PMID: 38791595 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical